Patent · US Active

Use of tumor gene methylation regulator and anti-tumor drugs

US11179349B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Inventors

Yang Qin · Menlo Park, US
Qing Dong · San Diego, US

Key dates

Filing date	Jan 24, 2017
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Jan 24, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/4702
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is the use of a tumor gene methylation regulator in preparing anti-tumor drugs. Furthermore, the tumor gene methylation regulator can be used as a sensitizer to be combined with a tumor therapeutic drug for preparing anti-tumor drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.